Download Files:
Ibiglustat
Price range: 53 CAD through 1,371 CAD
Products Details
Product Description
– Ibiglustat (GZ402671) is a potent and selective Glucosylceramide synthase inhibitor and ceramide glucosyltransferase inhibitor. Ibiglustat blocks the formation of glucosylceramide (GL-1), a key intermediate in the synthesis of GL-3. Ibiglustat is potentially useful for treating Fabry disease. Fabry disease is a rare lysosomal storage disorder, which results in abnormal tissue deposits of a particular fatty substance called globotriaosylceramide (GL-3 or Gb3) throughout the body.
Web ID
– T4473
Storage Temperature
– -20℃
Shipping
– Blue Ice
Molecular Formula
– C20H24FN3O2S
References
– Schiffmann R, et al. Fabry disease. Handb Clin Neurol. 2015;132:231-48.
CAS Number
– 1401090-53-6
Molecular Weight
– C20H24FN3O2S
Compound Purity
– 0.9914
SMILES
– CC(C)(NC(=O)O[C@@H]1CN2CCC1CC2)c1csc(n1)-c1ccc(F)cc1
Pathway
– Metabolism
Product type
– Small Compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
Related Products
1000 in stock
